biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by SayitLykitizon Jun 22, 2011 8:02pm

201 Views

Post# 18753197

RE: ok

I'll bite: I imagine that while most are holding tight to their holdings... others try to systematically walk the share price downward... to initiate a panic... and perhaps "shake out" the uncommitted.
If you can afford it... buy on these dips (under 0.40). I did this week @ .38 -my lowest purchase price yet!
Wake me up when it's at $5. Maybe 5 years from now? That would do me just fine, thank you.
GO BiOasis!

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments